Brazil announces positive results in “early” treatment for COVID-19

Two detainees after the discovery of 15,000 animals crammed into two houses in Mexico City

The Mexican National Guard seized this Thursday about 15,000 animals, including protected species, that were crowded into two buildings in eastern Mexico City, in...

Trump says he will leave the White House if the Electoral College confirms Biden

The Republican refuses to assume his defeat, insists on denouncing fraud at the polls and assures that until January 20 "a lot will happen"Still...

Trump: ‘I’ll leave White House when Biden has the most electors’

US President Donald Trump says he will hand over power to election winner Joe Biden in an orderly manner. "If it turns out...

The difficult return home at Christmas when PCR is worth more than the plane

The tourism sector and residents outside of Spain are pressing for the Government to also accept antigen tests, which are cheaper but less reliableGoing...

Merkel’s successor may keep a distance from China

Complicated relationship - this term is often used by experts, journalists and politicians to express an opinion on China-Germany relations. Berlin acts as...

The Government of Brazil announced this Monday that it obtained “positive results” in an “early” treatment against COVID-19, through the application of the antiparasitic nitazoxanida in patients who have the disease in its initial phase.

The announcement was made in an act led by the country’s president, Jair Bolsonaro, who recalled that at the time he defended the treatment of COVID-19 with hydroxychloroquine, which still sows doubts in the scientific community, and asked do not distrust now the possibilities that nitazoxanide can offer.

The results were presented by doctor Patricia Rocco, study coordinator and specialist in lung diseases with more than 30 years of experience, who said that the treatment showed that nitazoxanide was “effective” in reducing viral load of patients who had already contracted COVID-19.

Rocco explained that, between June and August, 1,575 volunteers who had coronavirus in an initial phase were treated with this drug and that in 95% of cases there was a reduction in viral load “without damage to lung cells” or other collateral problems.

The doctor indicated that the patients received 500 milligrams of nitazoxanide three times a day for five days, but he refrained from offering further details about the treatment because the study results have been sent to an international “major scientific journal” for collation.

“Low cost”

The Minister of Science and Technology, Marcos Pontes, said that “science is the only weapon that exists to fight the virus “and appreciated the effort made by the promoters of the study.

“We have a proven drug that is capable of reducing the viral load of the coronavirus, thereby reduces contagion and it reduces the possibility that the disease progresses with more force in the patient, “said Pontes.

“It is a low-cost drug, it works to reduce viral load, but it is not preventive, so it cannot be used before “a person contracts COVID-19, Pontes said.



Related Articles